Sanofi-Aventis Genzyme,
French pharmaceutical group Sanofi-Aventis announced Sunday a 18.5 billion dollars (14.5 million) cash bid for U.S. biotechnology firm Genzyme, or $ 69 a share.The offer no binding exclusively in cash,
Monday, August 30, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment